SLG
SWAV

Stanley-Laman Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Stanley-Laman Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47,471
Closed -$9.05M – 253
2023
Q4 		$9.05M Buy
+47,471
New +$8.97M 1.38% 9
2022
Q3 		– Sell
-13,129
Closed -$2.51M – 300
2022
Q2 		$2.51M Sell
13,129
-1,933
-13% -$341K 0.45% 91
2022
Q1 		$3.12M Buy
15,062
+1,957
+15% +$323K 0.43% 83
2021
Q4 		$2.34M Buy
+13,105
New +$2.58M 0.28% 126

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stanley-Laman Group's SWAV Position: Q1 2024 in Review

Stanley-Laman Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 47,471 shares — an estimated $9.05M sold.

Stanley-Laman Group first reported a position in SWAV in Q4 2021 and held it in 4 quarters. The position peaked at $9.05M in Q4 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Stanley-Laman Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Stanley-Laman Group sold 47,471 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $9.05M.
  • Stanley-Laman Group first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Stanley-Laman Group's Shockwave Medical, Inc. Common Stock position peaked at $9.05M in Q4 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Stanley-Laman Group's 13F filing for Q1 2024, filed 17 Apr 2024.